A Phase 2 trial of gemcabene in NASH patients

Trial Profile

A Phase 2 trial of gemcabene in NASH patients

Planning
Phase of Trial: Phase II

Latest Information Update: 14 Aug 2017

At a glance

  • Drugs Gemcabene (Primary)
  • Indications Non-alcoholic steatohepatitis
  • Focus Therapeutic Use
  • Acronyms AZURE-1
  • Most Recent Events

    • 14 Aug 2017 According to a Gemphire Therapeutics media release, top-line results for this study expected in second half of 2018.
    • 16 Mar 2017 New trial record
    • 15 Mar 2017 According to a Gemphire Therapeutics media release, company plans to initiate this trial in secon half of 2017 and anticipated to complete in the second half of 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top